We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-4.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$89.7B
AUM Growth
-$6.37B
Cap. Flow
-$1.25B
Cap. Flow %
-1.39%
Top 10 Hldgs %
19.07%
Holding
4,574
New
72
Increased
2,420
Reduced
1,279
Closed
355

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Healthcare 16.22%
3 Financials 13.45%
4 Consumer Discretionary 9.63%
5 Industrials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIG
4326
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$0 ﹤0.01%
127
+107
+535% +$506
AMYT
4327
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$0 ﹤0.01%
66
GLS
4328
DELISTED
Gelesis Holdings, Inc.
GLS
$0 ﹤0.01%
88
-41
-32% -$54
CDAK
4329
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
-8
Closed
ISO
4330
DELISTED
IsoPlexis Corporation Common Stock
ISO
-4
Closed
BOXD.WS
4331
DELISTED
Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share
BOXD.WS
$0 ﹤0.01%
80
PDOT.WS
4332
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$0 ﹤0.01%
177
WPCB
4333
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
-7,187
Closed -$70K
HERAW
4334
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$0 ﹤0.01%
22,738
SFT
4335
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
-3
Closed
RUBY
4336
DELISTED
Rubius Therapeutics, Inc
RUBY
-24
Closed
CAJ
4337
DELISTED
Canon, Inc.
CAJ
-4,399
Closed -$100K
MTCR
4338
DELISTED
Metacrine, Inc. Common Stock
MTCR
-244
Closed
HYRE
4339
DELISTED
HyreCar Inc. Common Stock
HYRE
-9
Closed
ZNH
4340
DELISTED
China Southern Airlines Company Limited
ZNH
-14,376
Closed -$416K
CEA
4341
DELISTED
China Eastern Airlines
CEA
-2,484
Closed -$47K
IVC
4342
DELISTED
Invacare Corporation
IVC
-18
Closed
NAAC
4343
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
-220,000
Closed -$2.17M
EAR
4344
DELISTED
Eargo, Inc. Common Stock
EAR
-1
Closed
OYST
4345
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
-6
Closed
RBCN
4346
DELISTED
Rubicon Technology, Inc.
RBCN
$0 ﹤0.01%
26
KAL
4347
DELISTED
Kalera Public Limited Company Ordinary Shares
KAL
-1
Closed
SCOAW
4348
DELISTED
ScION Tech Growth I Warrant
SCOAW
$0 ﹤0.01%
+1,552
New +$106
SCOA
4349
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
-403,957
Closed -$3.99M
HIIIW
4350
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$0 ﹤0.01%
10,000

Similar funds

Credit Suisse's Q3 2022 Portfolio in Review

As of Q3 2022, Credit Suisse held 4,574 positions worth $89.7B, down 6.6% from $96.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Credit Suisse's Q3 2022 filing shows 72 new, 2,420 increased, 1,279 reduced and 355 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $205M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q3 2022 buy was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M.
  • Credit Suisse added most to Apple in Q3 2022, an estimated $180M increase.
  • Credit Suisse's biggest Q3 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $205M.
  • Credit Suisse fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $40.9M.
  • Credit Suisse's ten largest holdings make up 19% of its $89.7B portfolio in Q3 2022.
  • Credit Suisse opened 72 new positions and closed 355 in Q3 2022.
  • Credit Suisse's portfolio value fell 6.6% quarter-over-quarter to $89.7B.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.